Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937392/
https://www.ncbi.nlm.nih.gov/pubmed/33688236
http://dx.doi.org/10.2147/IJNRD.S308249
_version_ 1783661382128893952
collection PubMed
description
format Online
Article
Text
id pubmed-7937392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79373922021-03-08 Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction] Int J Nephrol Renovasc Dis Retraction Dove 2021-03-03 /pmc/articles/PMC7937392/ /pubmed/33688236 http://dx.doi.org/10.2147/IJNRD.S308249 Text en © 2021 Dove Medical Press. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title_full Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title_fullStr Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title_full_unstemmed Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title_short Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
title_sort validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model” [retraction]
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937392/
https://www.ncbi.nlm.nih.gov/pubmed/33688236
http://dx.doi.org/10.2147/IJNRD.S308249

Ejemplares similares